檢索結果 - Jae‐Lyun Lee

Refine Results
  1. 1
    The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinoma

    The Association Between PD-L1 Expression and the Clinical Outcomes to Vascular Endothelial Growth Factor-Targeted Therapy in Patients With Metastatic Clear Cell Renal Cell Carcinom... 由 Su‐Jin Shin, Yoon Kyung Jeon, Yong Mee Cho, Jae‐Lyun Lee, Doo Hyun Chung, Ji Young Park, Heounjeong Go

    出版 2015
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  2. 2
    Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen

    Efficacy of Chemotherapy in Patients with Unresectable or Metastatic Pancreatic Acinar Cell Carcinoma: Potentially Improved Efficacy with Oxaliplatin-Containing Regimen 由 Changhoon Yoo, Bum Jun Kim, Kyu‐pyo Kim, Jae‐Lyun Lee, Tae Won Kim, Baek‐Yeol Ryoo, Heung-Moon Chang

    出版 2016
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  3. 3
    Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis in Korean Patients

    Bevacizumab Plus Erlotinib Combination Therapy for Advanced Hereditary Leiomyomatosis and Renal Cell Carcinoma-Associated Renal Cell Carcinoma: A Multicenter Retrospective Analysis... 由 Yeonjoo Choi, Bhumsuk Keam, Miso Kim, Shinkyo Yoon, Dalyong Kim, Jong Gwon Choi, Ja Young Seo, Inkeun Park, Jae‐Lyun Lee

    出版 2019
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  4. 4
    A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03)

    A Multicenter Phase II Study of Modified FOLFIRINOX for First-line Treatment for Advanced Urachal Cancer (ULTMA; KCSG GU20-03) 由 Inkeun Park, Jae‐Lyun Lee, Shinkyo Yoon, Sang Joon Shin, Seong Hoon Shin, Jung Hoon Kim, Kwonoh Park, Hyo Jin Lee

    出版 2025
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  5. 5
    Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study

    Systemic chemotherapy for treatment of advanced small bowel adenocarcinoma with prognostic factor analysis: retrospective study 由 Dong‐Hoe Koo, Sung‐Cheol Yun, Yong Sang Hong, Min‐Hee Ryu, Jae‐Lyun Lee, Heung-Moon Chang, Baek‐Yeol Ryoo, Yoon‐Koo Kang, Tae Won Kim

    出版 2011
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  6. 6
    Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy

    Prognostic factors and predictive model in patients with advanced biliary tract adenocarcinoma receiving first‐line palliative chemotherapy 由 Inkeun Park, Jae‐Lyun Lee, Min‐Hee Ryu, Tae‐Won Kim, Sung Sook Lee, Do Hyun Park, Sang Soo Lee, Dong Wan Seo, Sung Koo Lee, Myung‐Hwan Kim

    出版 2009
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  7. 7
    Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma

    Enfortumab Vedotin in Previously Treated Advanced Urothelial Carcinoma 由 Thomas Powles, Jonathan E. Rosenberg, Guru Sonpavde, Yohann Loriot, Ignacio Durán, Jae‐Lyun Lee, Nobuaki Matsubara, Christof Vulsteke, Daniel Castellano, Chunzhang Wu, Mary S. Campbell, Maria Matsangou, Daniel P. Petrylak

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  8. 8
    Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study

    Pyridoxine Is Not Effective to Prevent Hand-Foot Syndrome Associated With Capecitabine Therapy: Results of a Randomized, Double-Blind, Placebo-Controlled Study 由 Yoon‐Koo Kang, Sung Sook Lee, Dok Hyun Yoon, So‐Young Lee, Young Ju Chun, Min Sun Kim, Min‐Hee Ryu, Heung-Moon Chang, Jae‐Lyun Lee, Tae Won Kim

    出版 2010
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  9. 9
    Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma

    Efficacy of Savolitinib vs Sunitinib in Patients With<i>MET</i>-Driven Papillary Renal Cell Carcinoma 由 Toni K. Choueiri, Daniel Y.C. Heng, Jae‐Lyun Lee, Mathilde Cancel, Remy B. Verheijen, Anders Mellemgaard, Lone H. Ottesen, Melanie M. Frigault, Anne L’Hernault, Zsolt Szíjgyártó, Sabina Signoretti, Laurence Albigès

    出版 2020
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  10. 10
    <i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea

    <i>Chlamydia psittaci</i> infection and clinicopathologic analysis of ocular adnexal lymphomas in Korea 由 Changhoon Yoo, Min‐Hee Ryu, Jooryung Huh, Ji Hyun Park, Hye Jin Kang, Hyo Sook Ahn, Yongjae Lee, Myoung Joon Kim, Hyoungnam Lee, Tae Won Kim, Heung Moon Chang, Jae‐Lyun Lee, Yoon‐Koo Kang

    出版 2007
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  11. 11
    Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study

    Pazopanib for the Treatment of Non-clear Cell Renal Cell Carcinoma: A Single-Arm, Open-Label, Multicenter, Phase II Study 由 Ki Sun Jung, Su Jin Lee, Se Hoon Park, Jae‐Lyun Lee, Se‐Hoon Lee, Jae Yun Lim, Jung Hun Kang, Suee Lee, Sun Young Rha, Kyung Hee Lee, Ho Young Kim, Ho Yeong Lim

    出版 2017
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  12. 12
    YM155 Induces EGFR Suppression in Pancreatic Cancer Cells

    YM155 Induces EGFR Suppression in Pancreatic Cancer Cells 由 Young-Soon Na, Soo‐Jin Yang, Seung-Mi Kim, K.I. Jung, Jai-Hee Moon, Jae-Sik Shin, Dok Hyun Yoon, Yong Sang Hong, Min‐Hee Ryu, Jae‐Lyun Lee, Jung Shin Lee, Tae Won Kim

    出版 2012
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  13. 13
    Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF)

    Ring Finger Protein 149 Is an E3 Ubiquitin Ligase Active on Wild-type v-Raf Murine Sarcoma Viral Oncogene Homolog B1 (BRAF) 由 Seungwoo Hong, Dong‐Hoon Jin, Jae-Sik Shin, Jai-Hee Moon, Young-Soon Na, Kyung‐Ah Jung, Seung-Mi Kim, Jin Cheon Kim, Kyu‐pyo Kim, Yong Sang Hong, Jae‐Lyun Lee, Eun Kyung Choi, Jung Shin Lee, Tae Won Kim

    出版 2012
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  14. 14
    Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial

    Pembrolizumab plus lenvatinib as first-line therapy for advanced non-clear-cell renal cell carcinoma (KEYNOTE-B61): a single-arm, multicentre, phase 2 trial 由 Laurence Albigès, Howard Gurney, Vagif Atduev, Cristina Suárez, Miguel Ángel Climent, David Pook, Piotr Tomczak, Philippe Barthélémy, Jae‐Lyun Lee, V.P. Stus, Thomas Ferguson, Paweł Wiechno, Erhan Gökmen, Louis Lacombe, Craig Gedye, Rodolfo F. Perini, Manish Sharma, Xiang Peng, Chung‐Han Lee

    出版 2023
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  15. 15
    Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma

    Efficacy and Safety of Durvalumab in Locally Advanced or Metastatic Urothelial Carcinoma 由 Thomas Powles, Peter H. O’Donnell, Christophe Massard, Hendrik-Tobias Arkenau, Terence W. Friedlander, Christopher Hoimes, Jae‐Lyun Lee, Michael Ong, Srikala S. Sridhar, Nicholas J. Vogelzang, Mayer Fishman, Jingsong Zhang, Sandy Srinivas, Jigar Parikh, Joyce Antal, Xiaoping Jin, Ashok Gupta, Yong Ben, Noah M. Hahn

    出版 2017
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  16. 16
    Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial

    Safety of pazopanib and sunitinib in treatment-naive patients with metastatic renal cell carcinoma: Asian versus non-Asian subgroup analysis of the COMPARZ trial 由 Jun Guo, Jie Jin, Mototsugu Oya, Hirotsugu Uemura, Shunji Takahashi, Katsunori Tatsugami, Sun Young Rha, Jae‐Lyun Lee, Jinsoo Chung, Ho Yeong Lim, Hsi Chin Wu, Yen Chang, Arun Azad, Ian D. Davis, Marlene J. Carrasco-Alfonso, Bhupinder Nanua, Jackie Han, Qasim Ahmad, Robert J. Motzer

    出版 2018
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  17. 17
    Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma

    Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma 由 Cristiane Decat Bergerot, Sun Young Rha, Sumanta K. Pal, P. Koralewski, Daniil Stroyakovskiy, B. Yа. Alekseev, Francis Parnis, Daniel Castellano, Jae‐Lyun Lee, Kaisa Sunela, Tudor‐Eliade Ciuleanu, Daniel Y.C. Heng, Hilary Glen, Jinyi Wang, Lee Bennett, Janice Pan, Karen O’Hara, Javier Puente

    出版 2022
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  18. 18
    Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy

    Impact of Bone and Liver Metastases on Patients with Renal Cell Carcinoma Treated with Targeted Therapy 由 Rana R. McKay, Nils Kroeger, Wanling Xie, Jae‐Lyun Lee, Jennifer J. Knox, Georg A. Bjarnason, Mary J. MacKenzie, Lori Wood, Sandy Srinivas, Ulka N. Vaishampayan, Sun Young Rha, Sumanta K. Pal, Frede Donskov, Srinivas K. Tantravahi, Brian I. Rini, Daniel Y.C. Heng, Toni K. Choueiri

    出版 2013
    獲取全文
    Artigo
    加到收藏夾
    Saved in:
  19. 19
    Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma

    Open-Label, Single-Arm, Phase II Study of Pembrolizumab Monotherapy as First-Line Therapy in Patients With Advanced Non–Clear Cell Renal Cell Carcinoma 由 David F. McDermott, Jae‐Lyun Lee, Marek Ziobro, Cristina Suárez, Przemysław Langiewicz, В. Б. Матвеев, Paweł Wiechno, Rustem Gafanov, Piotr Tomczak, Fréderic Pouliot, Frede Donskov, B. Yа. Alekseev, Sang Joon Shin, Georg A. Bjarnason, Daniel Castellano, Rachel Kloss Silverman, Rodolfo F. Perini, Charles Schloss, Michael B. Atkins

    出版 2021
    獲取全文 獲取全文
    Artigo
    加到收藏夾
    Saved in:
  20. 20
    Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic Renal Cell Carcinoma

    Final Overall Survival and Molecular Analysis in IMmotion151, a Phase 3 Trial Comparing Atezolizumab Plus Bevacizumab vs Sunitinib in Patients With Previously Untreated Metastatic... 由 Robert J. Motzer, Thomas Powles, Michael B. Atkins, Bernard Escudier, David F. McDermott, B. Yа. Alekseev, Jae‐Lyun Lee, Cristina Suárez, Daniil Stroyakovskiy, Ugo De Giorgi, Frede Donskov, Begoña Mellado, Romain Banchereau, Habib Hamidi, Omara Khan, Veronica Craine, Mahrukh Huseni, Nick Flinn, Sarita Dubey, Brian I. Rini

    出版 2021
    獲取全文
    Artigo
    加到收藏夾
    Saved in:

檢索工具: